AdipoGen Life Sciences InVivoKines recombinant fusion proteins
InVivoKines are recombinant fusion proteins for immunotherapeutic, preclinical and translational in vivo research, developed in-house by AdipoGen Life Sciences. The company has leveraged knobs-into-holes (KIH) technology to develop monomeric, heterodimeric or homodimeric Fc fusion proteins.
Features include: native conformation (production in HEK 293 or CHO cells); production under animal-free conditions; high bioactivity tested by ELISA/cell-based assays; verified purity and homogeneity by SEC; low endotoxin levels; and batch-to-batch consistency.
InVivoKines are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
PhenoSys qOMR system for objective vision assessment in mice
PhenoSys introduces the qOMR (quantitative Optomotor Response) system, a fully automated platform...
OGT SureSeq Myeloid MRD Plus NGS Panel
OGT has launched its next-generation sequencing (NGS) panel for measurable residual disease...
Alithea Genomics MERCURIUS Spheroid DRUG-seq RNA sequencing library preparation kit
The kit enables researchers to bypass conventional RNA extraction and pre-amplification, enabling...
